Page last updated: 2024-08-16

pimobendan and saterinone

pimobendan has been researched along with saterinone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eschenhagen, T; Mende, U; Müller, FU; Neumann, J; Schmitz, W; Scholz, H1
Mende, U; Meyer, W; Neumann, J; Nose, M; Schmitz, W; Scholz, H; Starbatty, J; Stein, B; von der Leyen, H; Wenzlaff, H1

Other Studies

2 other study(ies) available for pimobendan and saterinone

ArticleYear
Phosphodiesterase inhibition and positive inotropy in failing human myocardium.
    Basic research in cardiology, 1992, Volume: 87 Suppl 1

    Topics: Benzimidazoles; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Heart; Humans; Imidazoles; Isoenzymes; Isometric Contraction; Isoproterenol; Myocardial Contraction; Myocardium; Organ Culture Techniques; Oxindoles; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Pyridazines; Pyridones

1992
Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
    Naunyn-Schmiedeberg's archives of pharmacology, 1991, Volume: 344, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Benzimidazoles; Calcium; Cardiac Output, Low; Cardiotonic Agents; Cyclic AMP; Female; Heart; Humans; Imidazoles; In Vitro Techniques; Isoenzymes; Male; Middle Aged; Myocardial Contraction; Myocardium; Ouabain; Oxindoles; Phosphodiesterase Inhibitors; Piperazines; Pyridazines; Pyridones

1991